Logo-ijhpm
Int J Health Policy Manag. 2021;10(3): 158-161. doi: 10.34172/ijhpm.2020.22
PMID: 32610783        PMCID: PMC7947902

Commentary

HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"

Michael Schlander 1,2 * ORCID

Cited by CrossRef:


1- Wale J, Thomas S, Hamerlijnck D, Hollander R. Patients and public are important stakeholders in health technology assessment but the level of involvement is low – a call to action. Res Involv Engagem. 2021;7(1) [Crossref]